Press Release: Precision BioSciences : Precision BioSciences to Participate in the 24th Annual Needham Virtual Healthcare Conference
DURHAM, N.C.--(BUSINESS WIRE)-- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing...
Read full article »
Precision Biosciences is a North Carolina-based biotechnology company that researches and develops gene editing therapies for the treatment of genetic and infectious diseases.
Read more